Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy

Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy

The overexpression of the pH regulator carbonic anhydrase IX (CAIX) due to hypoxic/metabolic stress was reported in various tumors as an adverse prognostic feature. Our retrospective study aimed to investigate the general pattern and dynamics of CAIX expression in rectal adenocarcinoma following pre...

Full description

Bibliographic Details
Main Authors:	Emese Sarolta Bádon, Lívia Beke, Attila Mokánszki, Csilla András, Gábor Méhes
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	International Journal of Molecular Sciences
Subjects:	rectal adenocarcinoma neoadjuvant treatment CAIX expression <i>KRAS</i> status
Online Access:	https://www.mdpi.com/1422-0067/24/3/2581

Similar Items

Quadruplicate Synchronous Adenocarcinoma of the Colon with Distant Metastases—Long-Term Molecular Follow-Up by KRAS and TP53 Mutational Profiling
by: Emese Sarolta Bádon, et al.
Published: (2020-06-01)

Clonal diversity in KRAS mutant colorectal adenocarcinoma under treatment: Monitoring of cfDNA using reverse hybridization and DNA sequencing platforms
by: Emese Sarolta Bádon, et al.
Published: (2023-02-01)

Early increase in circulating carbonic anhydrase IX: A potential new predictive biomarker of preeclampsia
by: Silvia Galbiati, et al.
Published: (2023-01-01)

Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression
by: Min-Chieh Hsin, et al.
Published: (2021-03-01)

Expression of Carbonic Anhydrase IX in NSCLC and its Relationship with VEGF and Ki67 Expression
by: Xiangfei ZHAO, et al.
Published: (2010-09-01)

Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
by: Fatma Sert, et al.
Published: (2023-10-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
by: Silvia Peppicelli, et al.
Published: (2020-01-01)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
by: Elena Andreucci, et al.
Published: (2019-01-01)

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model
by: Robin I. J. Merkx, et al.
Published: (2022-05-01)

Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis
by: Elena De Mattia, et al.
Published: (2023-02-01)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Anita De Rossi, et al.
Published: (2011-04-01)

Recent advance in neoadjuvant chemotherapy for rectal cancer
by: GUO Yang, GUO Tian′an, XU Ye
Published: (2022-07-01)

Neoadjuvant therapy for locally advanced rectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2022-06-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells
by: Ebru Temiz, et al.
Published: (2021-06-01)

Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer
by: Madison L. Conces, et al.
Published: (2024-01-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Interpretation of Rectal MRI after Neoadjuvant Treatment in Patients with Rectal Cancer
by: Nieun Seo, et al.
Published: (2023-05-01)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
by: Jian Wang, et al.
Published: (2021-07-01)

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery
by: Valerio Nardone, et al.
Published: (2022-06-01)

Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial
by: Shouki Bazarbashi, et al.
Published: (2022-05-01)

Evaluation of Response and Toxicity in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiation
by: Balaji Shewalkar, et al.
Published: (2023-07-01)

Guideline- Versus Non-Guideline-Based Neoadjuvant Management of Clinical T4 Rectal Cancer
by: Xi Chen, et al.
Published: (2023-10-01)

Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review
by: Aleksey A. Nevolskikh, et al.
Published: (2022-11-01)

Carbonic Anhydrase IX Suppression Shifts Partial Response to Checkpoint Inhibitors into Complete Tumor Eradication: Model-Based Investigation
by: Julia Grajek, et al.
Published: (2023-06-01)

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
by: Fokko J. Huizing, et al.
Published: (2021-07-01)

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
by: Wilson Eduardo Furlan Matos Alves, et al.
Published: (2019-12-01)

Total neoadjuvant therapy for rectal cancer: evidence and challenge
by: Suk-Hwan Lee
Published: (2023-08-01)

Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy
by: Salvador Sánchez-Vinces, et al.
Published: (2023-07-01)

Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
by: Yuhong Chen, et al.
Published: (2022-06-01)

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer
by: Chong Hui Clara Ong, et al.
Published: (2022-06-01)

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?
by: Ryosuke Okamura, et al.
Published: (2023-08-01)

Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia
by: Švitrigailė Grincevičienė, et al.
Published: (2024-04-01)

Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study
by: Yi‐min Han, et al.
Published: (2023-06-01)

Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study
by: Xiaoxue Huang, et al.
Published: (2023-03-01)

MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study
by: Yirong Xiang, et al.
Published: (2023-01-01)

Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data
by: Min Jung Kim, et al.
Published: (2018-10-01)

Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
by: Naohito Beppu, et al.
Published: (2023-01-01)